TY - JOUR
T1 - The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies
AU - Dunn, Katherine
PY - 2020/1/16
Y1 - 2020/1/16
N2 - It is often argued that DNA nanotechnology has a multitude of possible applications. However, despite great advances in the understanding of the fundamental principles of the field, to date, there has been comparatively little commercial activity. Analysis of patent applications and company case studies suggests that this is now starting to change. The number of patent application filings is increasing, and new companies are being formed to exploit technologies based on nanoscale structures and devices made from DNA. There are parallels between the commercial developments in this field and those observed in other areas of innovation. Further commercialization is expected and new players will emerge.
AB - It is often argued that DNA nanotechnology has a multitude of possible applications. However, despite great advances in the understanding of the fundamental principles of the field, to date, there has been comparatively little commercial activity. Analysis of patent applications and company case studies suggests that this is now starting to change. The number of patent application filings is increasing, and new companies are being formed to exploit technologies based on nanoscale structures and devices made from DNA. There are parallels between the commercial developments in this field and those observed in other areas of innovation. Further commercialization is expected and new players will emerge.
UR - https://www.mdpi.com/1420-3049/25/2/377
U2 - 10.3390/molecules25020377
DO - 10.3390/molecules25020377
M3 - Article
SN - 1420-3049
VL - 25
JO - Molecules
JF - Molecules
IS - 2
M1 - 377
ER -